Coagulation markers
| TCPC (n=8) | BDG (n=8) | All patients (n=16) | Controls (n=33) | |
| Prot C:c (U/ml) | 0.8 (0.6–0.8)2-150 | 0.7 (0.6–1.0) | 0.8 (0.6–0.8)2-151 | 1.0 (0.8–1.1) |
| Prot S Ag (U/ml) | 0.8 (0.7–0.9) | 0.7 (0.6–0.8)2-150 | 0.8 (0.6–0.8)2-151 | 0.9 (0.8–0.9) |
| AT-III (U/ml) | 0.9 (0.8–0.9)2-150 | 0.8 (0.7–0.8)2-150 | 0.8 (0.8–0.9)2-151 | 1.0 (0.9–1.0) |
| F1+2 (nmol/l) | 0.7 (0.5–0.8)2-150 | 0.8 (0.5–1.1)2-150 | 0.7 (0.5–0.9)2-151 | 1.3 (1.1–1.8) |
| II, VII ,X (rel U) | 0.6 (0.4–0.7)2-150 | 0.6 (0.5–0.7)2-150 | 0.6 (0.5–0.7)2-151 | 0.8 (0.8–0.9) |
| FVII:c (U/ml) | 0.7 (0.5–0.9)2-150 | 0.7 (0.6–0.8)2-150 | 0.7 (0.6–0.9)2-151 | 1.0 (0.8–1.1) |
Data are given as median (interquartile range).
↵2-150 p < 0.05;
↵2-151 p < 0.01 v controls.
AT-III, antithrombin III; BDG, bidirectional Glenn anastomosis; F1+2, prothrombin fragment 1 +2; FVII:c, factor VII clot activity; Prot C:c, protein C clot activity; Prot S Ag, protein S antigen; TCPC, total cavopulmonary anastomosis; II,VII,X, coagulation factor II,VII,X activity.